Tag Archives: neurodegenerative disease

April, 2018

July, 2017

May, 2017

October, 2016

  • 21 October

    FDA Accepts Resubmission of Teva’s Huntington Disease Drug

    JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of the New Drug Application (NDA) for SD-809 (deutetrabenazine) for the treatment of chorea associated with Huntington disease (HD). The FDA has assigned a Prescription Drug User Fee …

August, 2016

October, 2015